{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:13:08Z","timestamp":1760980388119,"version":"3.32.0"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"3b","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p>Alzheimer's disease (AD) is pathologically characterized by the accumulation of amyloid plaques and tau-associated neurofibrillary tangles in the cerebral tissue. The search for antemortem biomarkers is intense including analysis of cerebrospinal fluid (CSF) beta-amyloid and tau proteins concentrations seeking for an accurate and early diagnosis. Levels of hyperphosphorylated tau at threonine 181 were measured in the CSF of 34 patients with AD (19 with senile AD - SAD and eight with presenile AD - PSAD) and seven with other dementias (OD). The levels of CSF phosphotau were significantly higher in the AD patients compared to OD (AUC 0.812), with no association with severity of dementia, age of onset, duration of the disease or scores in the Mini-Mental State Examination. There were no differences of phosphotau levels between SAD and PSAD patients. These findings corroborate some previous studies and indicate that CSF phosphotau may help to differentiate AD from other dementias.<\/jats:p>","DOI":"10.1590\/s0004-282x2004000500001","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T14:39:12Z","timestamp":1113575952000},"page":"751-755","source":"Crossref","is-referenced-by-count":4,"title":["Hyperphosphorylated tau protein in the cerebrospinal fluid of patients with Alzheimer's disease and other dementias: preliminary findings"],"prefix":"10.1590","volume":"62","author":[{"given":"Ana Paula Barbosa Jeronimo","family":"Hartmann","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9rgio Monteiro de","family":"Almeida","sequence":"additional","affiliation":[{"name":"Federal University of Curitiba, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Livramento","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Nitrini","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Takahashi","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Caramelli","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00002093-200204000-00007","article-title":"Epidemiologic survey of dementia in a community-dwelling Brazilian population","volume":"16","author":"Herrera E Jr","year":"2002","journal-title":"Alzheimer Dis Assoc Disord","ISSN":"https:\/\/id.crossref.org\/issn\/0893-0341","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra SS","year":"1991","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00005072-198911000-00001","article-title":"Neuropathological diagnosis of Alzheimer disease","volume":"48","author":"Wisniewski HM","year":"1989","journal-title":"J Neuropathol Exp Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3069","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0197-4580(98)00018-9","article-title":"Cerebrospinal fluid tau protein as a potential diagnostic marker in Alzheimer's disease","volume":"19","author":"Arai H","year":"1998","journal-title":"Neurobiol Aging","ISSN":"https:\/\/id.crossref.org\/issn\/0197-4580","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow K","year":"1995","journal-title":"Mol Chem Neuropathol","ISSN":"https:\/\/id.crossref.org\/issn\/1044-7393","issn-type":"print"},{"key":"ref6","first-page":"581","article-title":"Antemortem CSF tau is related to neuronal pathology at autopsy in Alzheimer's disease","author":"Galasko D","year":"1995","journal-title":"Soc Neurosci Abstr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett GT","year":"1993","journal-title":"Neuron","ISSN":"https:\/\/id.crossref.org\/issn\/0896-6273","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1212\/WNL.45.4.788","article-title":"Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"45","author":"Vigo-Pelfrey C","year":"1995","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","article-title":"Molecular and Biochemical Markers of Alzheimer's Disease","volume":"19","year":"1998","journal-title":"Neurobiol Aging","ISSN":"https:\/\/id.crossref.org\/issn\/0197-4580","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(99)00617-5","article-title":"Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment","volume":"273","author":"Andreasen N","year":"1999","journal-title":"Neurosci Lett","ISSN":"https:\/\/id.crossref.org\/issn\/0304-3940","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0404.107.s179.9.x","article-title":"Cerebrospinal fluid levels of total-tau, phospho-tau and AB42 predicts development of Alzheimer's disease in patients with mild cognitive impairment","volume":"179","author":"Andreasen N","year":"2003","journal-title":"Acta Neurol Scand."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0304-3940(02)00047-2","article-title":"Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients","volume":"320","author":"Hu YY","year":"2002","journal-title":"Neurosci Lett","ISSN":"https:\/\/id.crossref.org\/issn\/0304-3940","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease","volume":"158","author":"Shoji M","year":"1998","journal-title":"J Neurol Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased B-amyloid and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease","volume":"289","author":"Sunderland T","year":"2003","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410440108","article-title":"Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan","volume":"44","author":"Kanai M","year":"1998","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","article-title":"Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?","volume":"71","author":"Kapaki E","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.58.11.1622","article-title":"Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration","volume":"58","author":"Riemenschneider M","year":"2002","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren M","year":"1993","journal-title":"J Neurochem","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(99)00476-0","article-title":"Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease","volume":"270","author":"Ishiguro K","year":"1999","journal-title":"Neurosci Lett","ISSN":"https:\/\/id.crossref.org\/issn\/0304-3940","issn-type":"print"},{"key":"ref20","series-title":"Alzheimer's disease: advances in ethiology, pathogenesis and therapeutics","first-page":"285","volume-title":"CSF-phosphotau (181P) as a promising marker for discriminating Alzheimer's disease from dementia with Lewy bodies","author":"Vanmechelen E","year":"2001"},{"key":"ref21","first-page":"77","article-title":"CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies: Phospho-Tau International Study Group","volume":"22","author":"Parnetti L","year":"2001","journal-title":"Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","article-title":"Microtubule-associated protein tau: abnormal phosphorylation of a non- paired helical filament pool in Alzheimer disease","volume":"268","author":"Kopke E","year":"1993","journal-title":"J Biol Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","article-title":"Both total and phosphorylated tau are increased in Alzheimer's disease","volume":"70","author":"Sjogren M","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen E","year":"2000","journal-title":"Neurosci Lett","ISSN":"https:\/\/id.crossref.org\/issn\/0304-3940","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann G","year":"1984","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia: The Lund and Manchester Groups","volume":"57","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref27","first-page":"189","article-title":"Clinical criteria for vascular dementia: the NINDS-AIREN criteria","volume":"5","author":"Erkinjuntti T","year":"1994","journal-title":"Dementia","ISSN":"https:\/\/id.crossref.org\/issn\/0913-6835","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith IG","year":"1996","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"year":"1992","series-title":"Clinical Neurology","author":"Mesulam M","key":"ref29"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.59.4.627","article-title":"CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects","volume":"59","author":"Buerger K","year":"2002","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v62n3b\/a01v623b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T18:31:04Z","timestamp":1735669864000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2004000500001&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":30,"journal-issue":{"issue":"3b","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0004-282X2004000500001"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2004000500001","relation":{},"ISSN":["0004-282X"],"issn-type":[{"type":"electronic","value":"0004-282X"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}